Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia (NARCIS)

Recruiting
18 years - 60 years
All
Phase N/A
70 participants needed
2 Locations

Brief description of study

This study evaluates the effect of a cognitive remediation program on neurocognitive, social cognitive and metacognitive functions designed for patients living with a schizophrenia spectrum disorder.

Detailed description of study

Evaluation of the specific therapeutic efficacy of the ecological cognitive remediation program for schizophrenia spectrum disorder [ECo-Sz] on neurocognitive deficits, social cognition deficits and metacognition deficits of patients with a schizophrenia spectrum disorder.

In this double-blind (patients, outcomes assessors) controlled randomized trial the investigators compare patients receiving Ecological Cognitive training program for schizophrenia spectrum disorder [ECo-Sz] to patients benefiting from recovery-oriented therapy [ThOR]. Patients are treated for two months and monitored for four months.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Schizophrenic Disorders
  • Age: 18 years - 60 years
  • Gender: All

Inclusion Criteria:

  • Schizophrenia Disorder diagnosis, according to Diagnostic and Statistical Manual of mental disorders - Fifth edition (DSM-V) - Patient stabilized in terms of positive and negative symptomatology (absence or presence of weak positive and negative symptoms)
  • Positive and Negative stable symptoms (no or few positive and negative symptoms)
  • Stable and effective minimum dose of medication (antipsychotic) for the last three months
  • Cognitive complaint expressed by the patient
  • Informed consent form read, initialed and signed
  • Understanding of spoken and read French
  • Patient registered on the social welfare system

Exclusion Criteria:

  • Other diagnosis at the forefront than Schizophrenia of the DSM-V
  • Medical history neurological disorder resulting in hospitalization
  • Acute episode in the last three month
  • Somatic disorders resulting in cognitive impairment
  • Engagement in a research protocol either currently or over the last month
  • Neuropsychological assessment evaluation during the last six month
  • Patients under the protection of a conservator (simple or reinforced)
  • Individuals in vulnerable circumstances

Updated on 02 Aug 2026. Study ID: 10477M-NARCIS

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Race
Select race of your choice
Ethnicity
Select ethinicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center